The pill makes good company on those days or nights when deadlines loom. Drowsiness and distractions evaporate. Focus sharpens. Attention span stretches. A boring text takes on the gleam of a riveting page-turner.
This is from students who, without a prescription, have popped Adderall or Ritalin, or another medication used to treat Attention Deficit Hyperactivity Disorder.
One fourth-year Engineering student, who requested anonymity, said he first took a friend's Adderall February of his first year, just when the work load picked up and everything was due at the same time.
He asked his friend a couple questions
Read More
U.Va. Health sees a spike in COVID-19 cases
By Emily Horn | September 4, 2023U.Va. Health ended their vaccination requirements in August, and masks were made optional in most hospital areas in early April.
U.Va. Cancer Center harnesses $12 million grant to support opportunities for undergraduates, ongoing research and new center
By Ellen Wu | January 12, 2023The grant provides an opportunity to establish the Center for Systems Analysis of Stress-Adapted Cancer Organelles, which seeks to find the cause of cancer in individual organelles.
U.Va. Health's rural neurology clinics receive a $500,000 grant to fund research and patient care
By Shrinidhi Kittur | January 12, 2023Established in the rural towns of Tazewell, Abingdon and Wise, the clinics have been providing patient care to otherwise underserved populations for decades.
